Criteria to qualify for study: | Drug used in study: |
---|---|
|
AMY 09 A single arm, open-label, phase 1/2 study of ZN-dS for the treatment of relapsed or refractory light chain (AL) Amyloidosis. |
Criteria to qualify for study: | Drug used in study: |
---|---|
|
AMY 09 A single arm, open-label, phase 1/2 study of ZN-dS for the treatment of relapsed or refractory light chain (AL) Amyloidosis. |